Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 7/20 | 0.74 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.73 |
| ▸ | SHBG | P04278 | 4/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.64 |
| ▸ | SERPINA6 | P08185 | 4/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 5/20 | 0.58 |
| ▸ | PGR | P06401 | 3/20 | 0.58 |
| ▸ | HRH1 | P35367 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 8/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | TSHR | P16473 | 2/20 | 0.57 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.57 |
| ▸ | KCNA1 | Q09470 | 1/20 | 0.57 |
| ▸ | SLC47A1 | Q96FL8 | 1/20 | 0.57 |
| ▸ | BLM | P54132 | 1/20 | 0.56 |
| ▸ | AR | P10275 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL143178 | 1.00 | NR3C1 (0.74) | NR3C1CYP2C19SHBGALDH1A1MAPK1 | |
| SCHEMBL18799367 | 0.88 | CYP2C19 (0.75) | NR3C1CYP2C19SHBGALDH1A1MAPK1 | |
| SCHEMBL4738 | 0.88 | NR3C1 (0.76) | NR3C1CYP2C19SHBGALDH1A1MAPK1 | |
| SCHEMBL722408 | 0.86 | SHBG (0.64) | NR3C1CYP2C19SHBGALDH1A1MAPK1 | |
| SCHEMBL11037287 | 0.86 | SHBG (0.72) | NR3C1CYP2C19SHBGALDH1A1MAPK1 | |
| Fludrocortisone SCHEMBL23975175 | 0.85 | NR3C1 (1.00) | NR3C1CYP2C19SHBGALDH1A1MAPK1 | |
| Fludrocortisone SCHEMBL10598529 | 0.85 | NR3C1 (1.00) | NR3C1CYP2C19SHBGALDH1A1MAPK1 | |
| Fludrocortisone SCHEMBL4323075 | 0.85 | NR3C1 (1.00) | NR3C1CYP2C19SHBGALDH1A1MAPK1 | |
| Fludrocortisone SCHEMBL19327146 | 0.85 | NR3C1 (1.00) | NR3C1CYP2C19SHBGALDH1A1MAPK1 | |
| Fludrocortisone SCHEMBL13026141 | 0.85 | NR3C1 (1.00) | NR3C1CYP2C19SHBGALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 22686 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747263-A1 | LIPID NANOPARTICLES AND USES THEREOF | University of Connecticut (US) | 2026-05-27 | — | — | EP | claimed |
| CN-116209439-B | Cereblon protein modulators | Saint Jude Children's Research Hospital Ltd. (US) | 2026-05-26 | — | — | CN | claimed |
| WO-2026102485-A1 | PRODUCTS AND METHODS FOR THE ASSESSMENT AND TREATMENT OF SEPSIS AND IMMUNOLOGICAL AND INFLAMMATORY CONDITIONS | CENTRAL ADELAIDE LOCAL HEALTH NETWORK INC (AU) | 2026-05-21 | — | — | WO | claimed |
| US-20260139030-A1 | CHIMERIC PROTEINS FOR TREATING CUTANEOUS INFLAMMATION | SHATTUCK LABS INC (US) | 2026-05-21 | — | — | US | claimed |
| WO-2026100654-A1 | NUCLEIC ACID INTRODUCTION AID, NUCLEIC ACID INTRODUCTION AGENT, AND NUCLEIC ACID INTRODUCTION METHOD | 株式会社インファーマシア | 2026-05-15 | — | — | WO | claimed |
| US-20260125650-A1 | METHODS AND COMPOSITIONS FOR GENERATING HEPATOCYTES | TRAILHEAD BIOSYSTEMS INC (US) | 2026-05-07 | — | — | US | claimed |
| WO-2026087695-A1 | TREATMENT FOR METABOLIC DISORDER | SAPREME TECHNOLOGIES B.V. (NL) | 2026-04-30 | — | — | WO | claimed |
| US-20260108610-A1 | Drug-Resistant Immune Cells and Methods of Use Thereof | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2026-04-23 | — | — | US | claimed |
| US-20260109699-A1 | AZOLE DERIVATIVES AS SHP2 INHIBITORS | IRBM S.P.A. (IT) | 2026-04-23 | — | — | US | claimed |
| EP-4728280-A1 | COMPOUNDS FOR DIAGNOSING AND TREATING EPILEPSY SYNDROMES, METHODS AND USES THEREOF | BIOSTRIKE UNIPESSOAL LDA (PT) | 2026-04-22 | — | — | EP | claimed |
| EP-0028110-B1 | AUTOCLAVABLE EMULSIONS | Smith and Nephew Associated Companies p.l.c. (GB) | 1984-03-07 | — | — | EP | claimed |
| WO-1983003968-A1 | BRAIN-SPECIFIC DRUG DELIVERY | UNIVERSITY OF FLORIDA (US) | 1983-11-24 | — | — | WO | claimed |
| US-4376767-A | ANTIBIOTICS AND PHARMACEUTICALS | MERCK & CO., INC. (US) | 1983-03-15 | — | — | US | claimed |
| US-4346709-A | Drug delivery devices comprising erodible polymer and erosion rate modifier | ALZA CORPORATION (US) | 1982-08-31 | — | — | US | claimed |
| EP-0055870-A1 | Pyridylmethyl esters of selected bio-affecting carboxylic acids, process for preparing and pharmaceutical composition comprising the same | MERCK & CO. INC. (US) | 1982-07-14 | — | — | EP | claimed |
| EP-0051278-A1 | Soft tertiary amine esters of bio-affecting carboxylic acids, processes for preparing and a pharmaceutical composition containing the same | MERCK & CO. INC. (US) | 1982-05-12 | — | — | EP | claimed |
| US-4279900-A | ANTIINFLAMMATORY | INTREX RESEARCH CORPORATION (US) | 1981-07-21 | — | — | US | claimed |
| EP-0028110-A2 | Autoclavable emulsions | Smith and Nephew Associated Companies p.l.c. (GB) | 1981-05-06 | — | — | EP | claimed |
| US-4083974-A | Topical steroidal anti-inflammatory preparations containing polyoxypropylene 15 stearyl ether | THE UPJOHN COMPANY (US) | 1978-04-11 | — | — | US | claimed |
| US-4041055-A | SULFENYLATION, MICHAEL ADDITION, REACTION WITH THIOPHILE, HYDROLYSIS | THE UPJOHN COMPANY (US) | 1977-08-09 | — | — | US | claimed |